γδ T cells in cancer
The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
With the promise of T cell-based therapy for cancer finally becoming reality, this Review focuses on the less-studied γδ T cell lineage and its diverse responses to tumours. γδ T cells have well-established protective roles in cancer, largely on the basis of their potent cytotoxicity and interferon-γ production. Besides this, recent studies have revealed a series of tumour-promoting functions that are linked to interleukin-17-producing γδ T cells. Here, we integrate the current knowledge from both human and mouse studies to highlight the potential of γδ T cell modulation to improve cancer immunotherapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“γδ T cells can have either protective roles or tumor-promoting functions in cancer; tumor-promoting activities of γδ T cells have been ascribed to distinct mechanisms in different types of cancers (Daley et al., 2016; Silva-Santos et al., 2015).”
From Commensal Microbiota Promote Lung Cancer Development via γδ T Cells (2019) · cites this paper as Silva-Santos et al., 2015
Citations
Cites
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Neoantigens in cancer immunotherapy
Schumacher, T. N., & Schreiber, R. D. (2015) · Science · doi:10.1126/science.aaa4971 · Cited by 4,783
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
The prognostic landscape of genes and infiltrating immune cells across human cancers
Gentles, A. J., Newman, A. M., Liu, C. L., Bratman, S. V., Feng, W., Kim, D., Nair, V. S., Xu, Y., Khuong, A., Hoang, C. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3909 · Cited by 3,118
Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms
Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3611 · Cited by 2,000
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
Coffelt, S. B., Kersten, K., Doornebal, C. W., Weiden, J., Vrijland, K., Hau, C.-S., Verstegen, N. J. M., Ciampricotti, M., Hawinkels, L. J. A. C., Jonkers, J., et al. (2015) · Nature · doi:10.1038/nature14282 · Cited by 1,703
Mittal, D., Gubin, M. M., Schreiber, R. D., & Smyth, M. J. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.01.004 · Cited by 1,471
Immune adaptations that maintain homeostasis with the intestinal microbiota
Hooper, L. V., & Macpherson, A. J. (2010) · Nature Reviews Immunology · doi:10.1038/nri2710 · Cited by 1,454
Six-of-the-best: unique contributions of γδ T cells to immunology
Vantourout, P., & Hayday, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3384 · Cited by 1,232
Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Research works printed but not linked: 1
- Gu, S., Nawrocka, W. & Adams, E. J. Sensing of pyrophosphate metabolites by Vγ9Vδ2 T cells. Front. Immunol. 5, 688 (2014).
Cited by
Items 501–593 of 593
Michielon, E., King, L. A., Waaijman, T., Veth, M., Spiekstra, S. W., van der Vliet, H. J., Gibbs, S., & de Gruijl, T. D. (2024) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2024.100724 · Cited by 4
Kong, D., & Guo, H. (2024) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.16044 · Cited by 1
Luo, X., Zhu, Y., Duan, X.-Q., Peng, W., Pei, C.-X., Yang, L., Li, Q., Zhao, M., & Wang, L. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf022 · Cited by 1
Association of Immune Cell Subsets With Longevity: The Cardiovascular Health Study
Dobrota, S. D., Bůžková, P., Delaney, J. A., Olson, N. C., Psaty, B. M., Huber, S. A., Doyle, M. F., Tracy, R. P., & Odden, M. C. (2025) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaf094 · Cited by 1
Pathology and Molecular Pathogenesis of T-Cell Lymphoma
Iqbal, J., & de Leval, L. (2018) · Springer Reference Medizin · doi:10.1007/978-3-030-00362-3_4 · Cited by 1
γδ T Cell Functions and Biology
Hayday, A., & Roberts, N. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.08010-3 · Cited by 1
Douguet, L. (2015) · theses.fr (ABES) · doi:10.70675/545bac4bz3a58z4433zae13z7dcd3b62df8a · Cited by 1
Editorial: Vγ9Vδ2 T cells: triple costimulation goes the distance
Sheridan, B. S., & Obar, J. J. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.1ce1115-522r
Inflammatory Cells and Mediators in the Tumor Microenvironment of Breast Cancer
Allaoui, R. (2017) · Lund University Publications (Lund University)
Multifaceted CK2 in malignant and healthy T cells
Ribeiro, S. T., Barata, J. T., & Silva‐Santos, B. (2017) · Oncotarget · doi:10.18632/oncotarget.21700
Self-citationExploring circulating biomarkers in patients with hepatocellular cancer
Ogle, L. F. (2017)
Methionine supplementation improves the efficacy of breast cancer immunotherapy
Pestana, T. R. G. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Recent Advances in Lung Immunobiology
Ramonell, R. P., Prasla, Z., Terry, C. R., Schulman, D. A., & Lee, F. E.-H. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0183ro
Influence des interactions avec le Soi sur le devenir des cellules T CD4 naïves en phase effectrice
Guichard, V. (2019) · theses.fr (ABES) · doi:10.70675/06681aaazd652z46c7zb83ez63059bc91f52
Elotuzumab enhances the anti-tumor activity of Vγ9Vδ2 T cells against primary effusion lymphoma
Maeda, K., Kariya, R., Panaampon, J., Matsuda, K., & Okada, S. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178922
Du développement des cellules iNKT humaines, à l'analyse de populations périphériques auto réactives
Perroteau, J. (2019) · theses.fr (ABES) · doi:10.70675/1d8f23a8z591fz4233z9ea8z702e5119a461
A Novel Function of Myc-nick, a Cleavage Product of c-Myc, in Resolution of Inflammation
종헌재 (2018) · Seoul National University Open Repository (Seoul National University)
Genomics-based Precision Medicine for Patients with Cancer
van de Haar, J. (2021) · Utrecht University Repository (Utrecht University) · doi:10.33540/946
Improving immunotherapy responses in gastrointestinal cancers
Chalabi, M. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/904
Rotte, A., & Bhandaru, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-48066-4_7
Research Progress of Biological Characteristics and Anti-Tumor Immunotherapy of γδ T Cells
刘, 义. (2021) · World Journal of Cancer Research · doi:10.12677/wjcr.2021.113011
(2019) · Molecular Imaging and Biology · doi:10.1007/s11307-019-01453-z
Zou, Q., Wang, S., Chen, Y., Du, Q., Zhang, C., Liu, J., & Yao, S. (2022) · Research Square · doi:10.21203/rs.3.rs-2320013/v1
Potential Roles of Infiltrated Immune Cells in the Tumour Microenvironment of Endometrial Cancer
Blemings-Derrick, J., Zinovkin, D. A., & Pranjol, M. Z. I. (2022) · Interdisciplinary cancer research · doi:10.1007/16833_2022_18 · Cited by 1
Residue communities reveal evolutionary signatures of γδ T-Cell receptorPreprint
Cheung, N. J., & Huang, S.-Y. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.29.522230
“The gamma delta T-cell receptors ( γδ TCRs) play an important biological role in human anti-infection immunity 18 , anti-tumor immunity 19 , tissue homeostasis 20 , and mucosal immunity 21 .”
BackgroundOrlova, E. G., Логинова, О. А., Loginova, N. P., Александровна, З. Н., Торсунова, Ю. П., & Ширшев, С. В. (2023) · Lecture notes in networks and systems · doi:10.1007/978-3-031-28086-3_50
Role of γδ T Cells in Cancer Progression and Therapy
Padmaraju, V., Sankla, Y., & Malla, R. R. (2023) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2023050067
Caractérisation d'une sous-population de LT γδ régulateurs dans les cancers solides humains
Chabab, G. (2022) · theses.fr (ABES) · doi:10.70675/71513c72z26faz4d27z9585za18dfdd957c9
Additional file 1 of Strategies to enhance CAR-T persistence
Liu, Y., An, L., Huang, R., Xiong, J., Yang, H., Wang, X., & Zhang, X. (2022) · Figshare · doi:10.6084/m9.figshare.21622536
The roles of MCPyV early region in IL-17A-mediated inflammation and autophagy
Miao, J. (2021) · theses.fr (ABES) · doi:10.70675/0ed263f9za522z491ezb888z3d6d2826cd2b
Quilbé, A. (2020) · theses.fr (ABES) · doi:10.70675/2cdccb2fz1d67z4693z837ezdc341116ff7c
[Advances in Pseudoprogression of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer].
Tong, Y., Long, Y., Zhang, F., & Li, J. (2024) · PubMed Central · doi:10.3779/j.issn.1009-3419.2024.101.10 · Cited by 2
Targeted Immunological Therapies in Dermatology
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4939-1
Chang, M., Wang, D., Feng, L., Jin, S., Zhou, Q., Wang, N., Wang, J., Ji, C., Lu, F., & Ye, J. (2025) · Holistic Integrative Oncology · doi:10.1007/s44178-025-00180-6
“Tregs, known for suppressing anti-tumor immunity, are associated with poor prognosis in various cancers [31]. γ-δ T cells are strongly linked to innate immunity and have been demonstrated to carry out antitumor cytotoxic responses through various effector mechanisms [32].”
Cao, Y., Liu, Y., Li, C., Guan, Y., Wu, Z., Zhang, S., Sun, X., Chen, J., & Yuan, Z. (2025) · Research Square · doi:10.21203/rs.3.rs-7266839/v1
“Additionally, we observed more prominent γδ T cell in�ltration in CR tumors (33, 34).”
Gatti, L. C. D. E., Nicolasen, M. J. T., Keramati, F., Brázda, P., Meringa, A. D., Bont, D. A. D., Aarts‐Riemens, T., Brandwijk, W. J. C., van der Wijst, M. I. M., Stuut, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.19.671055
Hayday, A., Vantourout, P., & Kabelitz, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00286-6
Dutta, S., Ganguly, A., & Roy, S. G. (2025) · International review of cytology · doi:10.1016/bs.ircmb.2025.08.011
Modeling Vγ9Vδ2 T-cell exhaustion in vitro: phenotypic and functional insights for immunotherapy
Chauvet, M., Léger, J., Laurent—Blond, M., Pecqueur, C., Harly, C., Bourges, D., & Scotet, E. (2025) · Blood Immunology & Cellular Therapy · doi:10.1016/j.bict.2025.100014
Wang, J., Ling, S., Ni, J., & Wan, Y. (2022) · Figshare · doi:10.6084/m9.figshare.20046965
Muller, C. K. S., Spagnuolo, J., Audigé, A., Chancellor, A., Russenberger, D., Scherrer, A. U., Hoffmann, M., Kouyos, R. D., Battegay, M., Libero, G. D., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14445105
Characterization of the role of XIAP in modulating inflammatory death and its consequences
Müller, N. (2019) · mediaTUM (Technical University of Munich) · Cited by 1
Investigation of T cell based therapeutic strategies to target Acute Myeloid Leukaemia
Wisidagamage Don, N. (2023) · UCL Discovery (University College London)
The Role of Chicken Gamma Delta T Cells in Immunity Against Marek’s Disease Virus
Matsuyama, A. (2023) · The Atrium (University of Guelph) · doi:10.1016/j.dci.2022.104391
Durchflusszytometrische Analyse von γδ-T-Zellen bei Patienten mit infektiöser Mononukleose
Bach, M. E., Behrends, U., & München, T. U. (2023)
Role of FcγRs in anti-OX40 based immunotherapies
Costoya, C. (2023) · UCL Discovery (University College London)
Segura-Garzón, D. (2024) · Open Research Online (The Open University)
Rosato, M., Vélez, P. S., Cruz, A. D. P. I., Pibuel, M. A., Fuentes, F., Vermeulen, M. E., Iturrizaga, J., Espil, P. E., Berner, S. I., Salamone, G. V., et al. (2026) · Biology · doi:10.3390/biology15030275
Selvam, C. P., Thacker, G., Kim, U., Tjendra, Y., Boone, M., Henry, S., dos Santos, C. O., & Chakrabarti, R. (2026) · Communications Biology · doi:10.1038/s42003-026-09897-0
“Recently growing research evidence indicates that γδ T-cells play a dual role in cancer progression 47,48 .”
Joalland, N., Lafrance, L., & Scotet, E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.25.714172
“…for cancer immunotherapy because they combine broad antitumor reactivity, major histocompatibility complex-independent recognition, and low alloreactivity, making them well suited for allogeneic adoptive cell transfer strategies (Wilhelm et al., 2003; Dieli et al., 2007; Silva-Santos et al., 2015).”
Humanized Mice as Models to study Human Innate Immunity and Immunotherapies
Lopez‐Lastra, S. (2017) · theses.fr (ABES) · doi:10.70675/332ff2f4z793bz4a95zbffcz4be18383be48
“Figure 11: Receptor-‐ligand interactions mediating tumor cell recognition by gamma delta (γδ) T cells (From Silva-‐Santos et al, 2015) Altogether, γδ-T cells show a very particular tissue-specific localization of oligoclonal subpopulations sharing the same TCR chains, making up…”
Caractérisation des lymphocytes T résidents des organes lymphoïdes secondaires à l’état basal
Audemard‐Verger, A. (2017) · theses.fr (ABES) · doi:10.70675/fb0b77fcz3b70z4f5czbf16z28f10ff2d116
Rôle de l'E3 ubiquitine ligase ASB2α dans le contrôle de la réponse immunitaire anti-tumorale
Spinner, C. A. (2018) · theses.fr (ABES) · doi:10.70675/20536a75za7d8z4249zbc3fz16ff73ed2d76
Bousset, L. (2019) · theses.fr (ABES) · doi:10.70675/45b0b676z18daz47a9zbb03zee607f300175 · Cited by 2
Vers la vectorisation des bisphophonates par les peptides de pénétration cellulaire
Guedeney, N. (2018) · theses.fr (ABES) · doi:10.70675/f400948bze29cz4a54za040z3f9e8793c16f
Physiologie de la réponse et de la tolérance immunes dans l'épididyme murin
Voisin, A. (2018) · theses.fr (ABES) · doi:10.70675/a8c99a9azbe70z44c5z99cczfa36fe5cd0bd · Cited by 1
Identification de nouvelles pistes de ciblage thérapeutique dans le lymphome folliculaire
Rossi, C. (2018) · theses.fr (ABES) · doi:10.70675/816b7c32z8a55z4ebczb2e2zc6f6dc3a248a
Réponses lymphocytaires T dans le contexte des infections par le virus de l'hépatite E
Barragué, H. (2018) · theses.fr (ABES) · doi:10.70675/76b4d5f8z476dz40a4za78cz2fdd2cac67ff
Activation des lymphocytes T gamma delta dans les cancers
Laplagne, C. (2020) · theses.fr (ABES) · doi:10.70675/7f8ae6ddz0e42z4c41z838fz044b72328b9c
Régulation des lymphocytes T innés par le microbiote intestinal
Dupraz, L. (2019) · theses.fr (ABES) · doi:10.70675/935b418azb404z4441z9030z12893629cebc
Targeting intracellular inhibiting proteins DOK1 and DOK2 to improve CD8+ T cell immunotherapy
Laletin, V. (2022) · theses.fr (ABES) · doi:10.70675/1a7b3c80z5230z4873zae5bz041d08701587
Pelletier, B. (2024) · theses.fr (ABES) · doi:10.70675/fa5b6b6cz9ab0z4a27zba5ezd3079d769043
Wang, F., Zhao, J., Zhang, T., & Shi, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1827307
Involvement of immunomodulators in the development of cancer vaccines
Bibi, R., Swayamsiddhi, Saishree, S., Sobti, M., Reddy, S., & Sarkar, K. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168321
Immunological Interactions Between Gammadelta T Cells and West Nile Virus in the Infected Host
Cimini, E., Tartaglia, E., Cristofanelli, F., Gili, S., & Maggi, F. (2026) · Reviews in Medical Virology · doi:10.1002/rmv.70176
“Once activated with N‐BPs, Vδ2 cells are potent cytotoxic effector cells [85] against malignancies [86, 87] and HIV‐infected cells [88–91].”
Oligoclonal expansion of atypical Vδ2− γδ T cells in Good’s Syndrome
Bandala‐Sanchez, E., Scolamiero, L., Chatelier, J., Ramsay, K. A., Morey, A., Tsang, S. Y., Forde, M., Bosco, J. J., Pumar, M., Sánchez‐Ramón, S., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74273-9 · Cited by 1
Potential Roles of Gamma-Delta T Cells in a Bacterial Immun-Ization Model
Talbot, L. A., Manjikian, R., & Bitsaktsis, C. (2026) · Vaccines · doi:10.3390/vaccines14070590
CAR-T cell therapy in glioblastoma: from αβ to γδ T-cell platforms
Dieli, C., Costanzo, R., Corsale, A. M., Paolini, F., Simone, M. D., Avellone, C., Dieli, F., Iacopino, D. G., Marchiafava, S., Maugeri, R., et al. (2026) · Oncology Reviews · doi:10.3389/or.2026.1808229
“Among these, γδ T-cell have emerged as a particularly attractive candidate due to their MHC-independent tumor recognition and innate-like response (16, 17), reduced risk of graft-versus-host disease, and ability to respond to stress-induced ligands abundantly expressed by GBM cells.”
TGF-β controls developmental fate and functional identity of thymic γδ T cells
Han, J., Zhang, T., Zhang, D., Liu, N., Jin, W., Ma, Z., & Chen, W. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag134
Cell-Type-Tailored Hydrogels for Adoptive Cell Therapy in Cancer
Shin, J. H., Song, Y., & Park, J. (2026) · Gels · doi:10.3390/gels12080678
“Distinct γδ T-cell subsets differ in integrin expression and trafficking, which may influence the balance between local retention and tissue infiltration [118].”
γδ T Cells as a Platform for Immunotherapy: From Biological Principles to Clinical Translation
Ni, J., Xiong, C., Wu, X., Yuan, Z., Wang, X., Chen, Y., Wu, X., Li, M., Du, F., Zhao, Y., et al. (2026) · Immunological Investigations · doi:10.1080/08820139.2026.2711303
Challenges and Opportunities of γδ T Cell-Based Immunotherapy for Glioblastoma
Chao, C., Shen, H.-T. E., Zhang, B.-X. B., Chao, T.-H. C., Wang, C.-D. W., & Wu, C.-C. (2026) · Biomedicines · doi:10.3390/biomedicines14081770
Zhu, Z., 江建蘋, Cao, M., & Cao, D. (2026) · Cancer Management and Research · doi:10.2147/cmar.s624716
“15 In several malignancies, such as lung cancer, previous studies have shown that the infiltration/expansion of γδ T cells is associated with a better prognosis.”
Enrichment of CD4−CD8− cytotoxic Vδ1/3 T cells in pulmonary tuberculosis disease
Kearns, K., Tippalagama, R., Chawla, A., Greenbaum, J., Silva, A. D. D., Gunasinghe, W., Perera, J., Gunasekera, H., Senevirathne, D. D., Scriba, T. J., et al. (2026) · iScience · doi:10.1016/j.isci.2026.117241
Xing, S., 张佳宇, Wang, S., Hao, Y., Huang, D., Hao, M., Bao, W., Qu, X., Chi, Y., & Li, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1923822
Wang, Y., He, Y., Xu, J., Wang, Y., Su, H., Zhang, Y., Lv, J., Chen, H., & Wang, J. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105636
Li, X., Qu, X., & An, Y.-T. (2026) · Research Square · doi:10.21203/rs.3.rs-10972542/v1
ScRNAseq reveals allergen-specific signatures in human gdT cells
Kearns, K. (2026) · ImmPort · doi:10.21430/m3tt705get
Sayed, U., Rizaev, J. A., Polatova, D. S., Abdulqader, A. F., Jbar, R. M., Maharana, L., Singhal, D., & Tailor, N. K. (2026) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2026.101512
Metadata
- Authors
- Silva-Santos, B., Serre, K., & Norell, H.
- Affiliations
- University of Lisbon (PT)
- Corresponding author
- Serre, Karine
- Venue
- Nature reviews. Immunology
- Published
- 2015-10-09
- Volume
- 15
- Issue
- 11
- Pages
- 683-691
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2183777144
- Cited by
- 565
- References
- 95
- Citations by year
- 2026: 30 · 2025: 43 · 2024: 39 · 2023: 60 · 2022: 72 · 2021: 59 · 2020: 63 · 2019: 54 · 2018: 55 · 2017: 56 · 2016: 33
- FWCI
- 4.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- γδ T cells, cancer immunotherapy, tumour immunity, cytotoxicity, interferon-gamma, IL-17, T cell regulation
- MeSH terms
- Animals, Cytotoxicity, Immunologic, Humans, Neoplasms, T-Lymphocytes, Receptors, Antigen, T-Cell, gamma-delta, Interleukin-17, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.